US2685553A
(en)
|
1951-03-30 |
1954-08-03 |
Winthrop Stearns Inc |
Cement coated tablets
|
DE2010416B2
(de)
|
1970-03-05 |
1979-03-29 |
Hoechst Ag, 6000 Frankfurt |
Oral anwendbare Arzneiform mit Retardwirkung
|
DE2815926A1
(de)
|
1978-04-13 |
1979-10-18 |
Boehringer Mannheim Gmbh |
Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
CA1018456A
(en)
|
1972-06-26 |
1977-10-04 |
Hans Lowey |
Prolonged release lozenges
|
JPS5518694B2
(ru)
|
1973-04-02 |
1980-05-21 |
|
|
US4034758A
(en)
|
1975-09-08 |
1977-07-12 |
Alza Corporation |
Osmotic therapeutic system for administering medicament
|
US4330338A
(en)
|
1978-10-02 |
1982-05-18 |
Purdue Research Foundation |
Pharmaceutical coating composition, and preparation and dosages so coated
|
US4449983A
(en)
|
1982-03-22 |
1984-05-22 |
Alza Corporation |
Simultaneous delivery of two drugs from unit delivery device
|
US4389393A
(en)
|
1982-03-26 |
1983-06-21 |
Forest Laboratories, Inc. |
Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
|
DE3320583A1
(de)
|
1983-06-08 |
1984-12-13 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
|
AU591171B2
(en)
|
1983-11-02 |
1989-11-30 |
Alza Corporation |
Dispenser for delivering thermo-responsive composition
|
US4844984A
(en)
|
1984-03-19 |
1989-07-04 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
JPH0246008B2
(ja)
|
1984-06-01 |
1990-10-12 |
Takada Seiyaku Kk |
Nifuejipinjizokuseiseizainoseizohoho
|
GB2170104A
(en)
|
1985-01-30 |
1986-07-30 |
Warner Lambert Co |
Coated pharmaceutical dosage forms
|
ES8801121A1
(es)
|
1985-02-19 |
1988-01-01 |
Key Pharma |
Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.
|
US4898733A
(en)
|
1985-11-04 |
1990-02-06 |
International Minerals & Chemical Corp. |
Layered, compression molded device for the sustained release of a beneficial agent
|
US4892742A
(en)
|
1985-11-18 |
1990-01-09 |
Hoffmann-La Roche Inc. |
Controlled release compositions with zero order release
|
US4824675A
(en)
|
1987-07-13 |
1989-04-25 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
WO1989009066A1
(en)
|
1988-03-24 |
1989-10-05 |
Bukh Meditec A/S |
Controlled release composition
|
FI101344B
(fi)
|
1988-03-31 |
1998-06-15 |
Tanabe Seiyaku Co |
Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseut tisesti aktiivista ainetta
|
JPH07100191B2
(ja)
|
1989-01-04 |
1995-11-01 |
古河電気工業株式会社 |
ブランキング方法
|
ES2054333T3
(es)
|
1989-01-30 |
1994-08-01 |
Alza Corp |
Forma de dosificacion para administrar un antagonista del calcio.
|
US5019396A
(en)
|
1989-05-12 |
1991-05-28 |
Alza Corporation |
Delivery dispenser for treating cardiac arrhythmias
|
DK469989D0
(da)
|
1989-09-22 |
1989-09-22 |
Bukh Meditec |
Farmaceutisk praeparat
|
IT1237904B
(it)
|
1989-12-14 |
1993-06-18 |
Ubaldo Conte |
Compresse a rilascio a velocita' controllata delle sostanze attive
|
EP0435726B1
(en)
|
1989-12-29 |
1994-11-09 |
Bristol-Myers Squibb Company |
Capsule and caplet combination
|
US5102668A
(en)
|
1990-10-05 |
1992-04-07 |
Kingaform Technology, Inc. |
Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
|
GB9025372D0
(en)
|
1990-11-22 |
1991-01-09 |
Nat Res Dev |
Pharmaceutical dosage forms
|
GB9101502D0
(en)
|
1991-01-23 |
1991-03-06 |
Controlled Therapeutics Sct |
Controlled release compositions
|
US5656295A
(en)
|
1991-11-27 |
1997-08-12 |
Euro-Celtique, S.A. |
Controlled release oxycodone compositions
|
US5266331A
(en)
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US5478577A
(en)
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
SE9202250D0
(sv)
|
1992-07-29 |
1992-07-29 |
Gacell Lab Ab |
Controlled release morphine preparation
|
US5609885A
(en)
|
1992-09-15 |
1997-03-11 |
Alza Corporation |
Osmotic membrane and delivery device
|
US5869097A
(en)
|
1992-11-02 |
1999-02-09 |
Alza Corporation |
Method of therapy comprising an osmotic caplet
|
US5881926A
(en)
|
1993-03-11 |
1999-03-16 |
Taro Pharmaceutical Industries, Ltd. |
Pharmaceutical compositions in semisolid form and a device for administration thereof
|
SE9301057L
(sv)
|
1993-03-30 |
1994-10-01 |
Pharmacia Ab |
Beredning med kontrollerad frisättning
|
US5656291A
(en)
|
1994-03-16 |
1997-08-12 |
Pharmacia & Upjohn Aktiebolag |
Controlled release preparation
|
IL110014A
(en)
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US5879705A
(en)
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
US6183778B1
(en)
|
1993-09-21 |
2001-02-06 |
Jagotec Ag |
Pharmaceutical tablet capable of liberating one or more drugs at different release rates
|
JPH07100191A
(ja)
|
1993-10-06 |
1995-04-18 |
Daikyo Yakuhin Kogyo Kk |
徐放性坐剤
|
US5419917A
(en)
|
1994-02-14 |
1995-05-30 |
Andrx Pharmaceuticals, Inc. |
Controlled release hydrogel formulation
|
AU1806895A
(en)
|
1994-02-23 |
1995-09-11 |
Bm Research A/S |
Controlled release composition
|
US6077533A
(en)
|
1994-05-25 |
2000-06-20 |
Purdue Pharma L.P. |
Powder-layered oral dosage forms
|
US5411745A
(en)
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
US7060293B1
(en)
|
1994-05-25 |
2006-06-13 |
Purdue Pharma |
Powder-layered oral dosage forms
|
US5460826A
(en)
|
1994-06-27 |
1995-10-24 |
Alza Corporation |
Morphine therapy
|
US6491945B1
(en)
|
1994-09-16 |
2002-12-10 |
Alza Corporation |
Hydrocodone therapy
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
IL139728A
(en)
|
1995-01-09 |
2003-06-24 |
Penwest Pharmaceuticals Compan |
Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
|
EP0835101B1
(en)
|
1995-06-27 |
2004-06-09 |
Takeda Chemical Industries, Ltd. |
Method of producing sustained-release preparation
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
US6245351B1
(en)
|
1996-03-07 |
2001-06-12 |
Takeda Chemical Industries, Ltd. |
Controlled-release composition
|
WO1997033566A2
(en)
|
1996-03-12 |
1997-09-18 |
Alza Corporation |
Composition and dosage form comprising opioid antagonist
|
ES2319699T3
(es)
|
1996-05-20 |
2009-05-11 |
Otsuka Pharmaceutical Co., Ltd. |
Remedio para la rosacea.
|
US6348216B1
(en)
|
1996-06-10 |
2002-02-19 |
Knoll Pharmaceutical Company |
Ibuprofen and narcotic analgesic compositions
|
US6361794B1
(en)
|
1996-06-12 |
2002-03-26 |
Basf Corporation |
Method of making ibuprofen and narcotic analgesic composition
|
DE59702733D1
(de)
|
1996-08-15 |
2001-01-11 |
Losan Pharma Gmbh |
Gut schluckbare orale arzneiform
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
US6046177A
(en)
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
EA002482B1
(ru)
|
1997-07-01 |
2002-06-27 |
Пфайзер Инк. |
Соли сертралина и лекарственные формы с длительным высвобождением сертралина
|
US6730326B2
(en)
|
1997-07-22 |
2004-05-04 |
Roche Diagnostics Gmbh |
Thermodynamically stable modification of 1-(4-carbazolyl-oxy-3[2-(2-methoxyphenoxy)-ethylamino]-2-propanol process for its preparation and pharmaceutical compositions containing it
|
US6607751B1
(en)
|
1997-10-10 |
2003-08-19 |
Intellipharamaceutics Corp. |
Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
|
US6066339A
(en)
|
1997-10-17 |
2000-05-23 |
Elan Corporation, Plc |
Oral morphine multiparticulate formulation
|
US20020054911A1
(en)
|
2000-05-11 |
2002-05-09 |
Boehringer Mannheim Pharmaceutical Corporation-Sm Ithkline Beckman Corporation, Limited Partnershi |
Novel oral dosage form for carvedilol
|
CZ299283B6
(cs)
|
1997-12-22 |
2008-06-04 |
Euro-Celtique, S. A. |
Léková forma pro perorální podání
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
FR2774910B1
(fr)
|
1998-02-16 |
2001-09-07 |
Ethypharm Lab Prod Ethiques |
Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques
|
US8524277B2
(en)
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US6350470B1
(en)
|
1998-04-29 |
2002-02-26 |
Cima Labs Inc. |
Effervescent drug delivery system for oral administration
|
EP1067910B1
(en)
|
1998-04-03 |
2004-05-26 |
Egalet A/S |
Controlled release composition
|
US7906143B1
(en)
|
1998-10-05 |
2011-03-15 |
Intellipharmaceutics Corp |
Controlled release pharmaceutical delivery device and process for preparation thereof
|
US20080102121A1
(en)
|
1998-11-02 |
2008-05-01 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
|
US20080113025A1
(en)
|
1998-11-02 |
2008-05-15 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
|
EP1027888B1
(en)
|
1999-02-10 |
2009-06-10 |
Pfizer Products Inc. |
Osmotic system for delivery of solid amorphous dispersions of drugs
|
JP4812167B2
(ja)
|
1999-02-12 |
2011-11-09 |
モレキュラー インサイト ファーマスーティカルズ インコーポレイテッド |
薬物輸送用マトリックス、ならびにその作成方法および使用方法
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
FR2794646B1
(fr)
|
1999-06-09 |
2001-09-21 |
Ethypharm Lab Prod Ethiques |
Microgranules de sulfate de morphine, procede de preparation et composition les contenant
|
US6225343B1
(en)
|
1999-06-16 |
2001-05-01 |
Nastech Pharmaceutical Company, Inc. |
Compositions and methods comprising morphine gluconate
|
US20030118641A1
(en)
|
2000-07-27 |
2003-06-26 |
Roxane Laboratories, Inc. |
Abuse-resistant sustained-release opioid formulation
|
US6562375B1
(en)
|
1999-08-04 |
2003-05-13 |
Yamanouchi Pharmaceuticals, Co., Ltd. |
Stable pharmaceutical composition for oral use
|
US6534085B1
(en)
|
1999-09-23 |
2003-03-18 |
Bioresponse L.L.C. |
Phytochemicals for promoting weight loss
|
KR20130010512A
(ko)
|
1999-10-29 |
2013-01-28 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
EP1233768A1
(en)
|
1999-11-15 |
2002-08-28 |
Smithkline Beecham |
Carvedilol methanesulfonate
|
US6458824B1
(en)
|
1999-11-30 |
2002-10-01 |
Dainippon Pharmaceutical Co., Ltd. |
Solid preparation
|
US6491949B2
(en)
|
2000-01-14 |
2002-12-10 |
Osmotica Corp. |
Osmotic device within an osmotic device
|
US6352721B1
(en)
|
2000-01-14 |
2002-03-05 |
Osmotica Corp. |
Combined diffusion/osmotic pumping drug delivery system
|
AR028253A1
(es)
|
2000-03-16 |
2003-04-30 |
Pfizer Prod Inc |
Inhibidores de la glucogeno fosforilasa
|
JP2003528914A
(ja)
|
2000-04-03 |
2003-09-30 |
エフ.ホフマン−ラ ロシュ アーゲー |
カルベジロールの濃縮溶液
|
US20010036959A1
(en)
|
2000-04-03 |
2001-11-01 |
Gabel Rolf Dieter |
Carvedilol-hydrophilic solutions
|
US6488962B1
(en)
|
2000-06-20 |
2002-12-03 |
Depomed, Inc. |
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
|
WO2002065834A2
(en)
|
2000-10-24 |
2002-08-29 |
Smithkline Beecham Corporation |
Novel formulations of carvedilol
|
EP1337244A4
(en)
|
2000-10-30 |
2006-01-11 |
Euro Celtique Sa |
HYDROCODON FORMULATIONS WITH CONTROLLED RELEASE
|
ATE293439T1
(de)
|
2000-12-07 |
2005-05-15 |
Warner Lambert Co |
Verfahren und system zur gleichmä igen arzneistoffabgabe
|
US6800668B1
(en)
|
2001-01-19 |
2004-10-05 |
Intellipharmaceutics Corp. |
Syntactic deformable foam compositions and methods for making
|
UA81224C2
(ru)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозированная форма оксикодона и ее применение
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
IN191028B
(ru)
|
2001-05-17 |
2003-09-13 |
Sun Pharmaceutical Ind Ltd |
|
US7144587B2
(en)
|
2001-08-06 |
2006-12-05 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent
|
DE20220917U1
(de)
*
|
2001-08-06 |
2004-08-19 |
Euro-Celtique S.A. |
Zusammensetzungen zur Verhinderung des Missbrauchs von Opioiden
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US7842307B2
(en)
|
2001-08-06 |
2010-11-30 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
|
US7332182B2
(en)
|
2001-08-06 |
2008-02-19 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
|
WO2003024429A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Polymer release system
|
WO2003024430A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Morphine polymer release system
|
EP1929998A3
(en)
|
2001-09-21 |
2008-11-26 |
Egalet A/S |
Controlled release solid dispersions of carvedilol
|
BR0212951A
(pt)
|
2001-09-28 |
2004-10-26 |
Mcneil Ppc Inc |
Formas de dosagens compósitas
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US20060039958A1
(en)
|
2003-05-28 |
2006-02-23 |
Monosolrx, Llc. |
Multi-layer films having uniform content
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US7666337B2
(en)
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
ITMI20012366A1
(it)
|
2001-11-09 |
2003-05-09 |
Farmatron Ltd |
Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
|
EP1471891A4
(en)
|
2002-02-08 |
2007-04-11 |
Alkermes Inc |
POLYMER-BASED COMPOSITIONS FOR PROLONGED RELEASE
|
ITMI20020514A1
(it)
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
|
JP2005526079A
(ja)
|
2002-03-15 |
2005-09-02 |
サイプレス バイオサイエンス, インコーポレイテッド |
内蔵痛症候群を処置するためのneおよび5−ht再取り込み阻害剤
|
DK1578350T3
(da)
|
2002-03-26 |
2009-08-10 |
Euro Celtique Sa |
Sammensætninger med gel-coating med depotvirkning
|
US8017150B2
(en)
|
2002-04-11 |
2011-09-13 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US20050106249A1
(en)
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
WO2003092648A1
(en)
|
2002-04-29 |
2003-11-13 |
Alza Corporation |
Methods and dosage forms for controlled delivery of oxycodone
|
DE10223844B4
(de)
|
2002-05-28 |
2013-04-04 |
Danfoss A/S |
Wasserhydraulische Maschine
|
EP1513497A2
(en)
|
2002-05-31 |
2005-03-16 |
Alza Corporation |
Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
|
AR039744A1
(es)
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
US6632832B1
(en)
|
2002-09-10 |
2003-10-14 |
Dabur Research Foundation |
Anti-cancer activity of carvedilol and its isomers
|
WO2004041252A1
(en)
|
2002-11-08 |
2004-05-21 |
Egalet A/S |
Controlled release carvedilol compositions
|
US20040089605A1
(en)
|
2002-11-08 |
2004-05-13 |
Harry Brandt |
Reverse osmosis liquid purification system and method
|
US20040102476A1
(en)
|
2002-11-25 |
2004-05-27 |
Chan Tai Wah |
High concentration formulations of opioids and opioid derivatives
|
EP2959893A1
(en)
|
2002-12-13 |
2015-12-30 |
DURECT Corporation |
Oral drug delivery system comprising high viscosity liquid carrier materials
|
EP1572164A2
(en)
|
2002-12-18 |
2005-09-14 |
Pain Therapeutics, Inc. |
Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
|
ES2570454T3
(es)
|
2003-03-26 |
2016-05-18 |
Egalet Ltd |
Sistema de liberación controlada de morfina
|
EP1974726B1
(en)
|
2003-03-26 |
2010-01-13 |
Egalet A/S |
Matrix compositions for controlled delivery of drug substances
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
AU2004232370B2
(en)
|
2003-04-21 |
2009-12-10 |
Euro-Celtique S.A. |
Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
|
US8168218B2
(en)
|
2003-04-24 |
2012-05-01 |
Jagotec Ag |
Delayed release tablet with defined core geometry
|
US8029822B2
(en)
|
2003-05-22 |
2011-10-04 |
Osmotica Kereskedelmi és Seolgáltató KFT |
Rupturing controlled release device having a preformed passageway
|
US20060177507A1
(en)
|
2003-05-22 |
2006-08-10 |
Joaquina Faour |
Controlled release device containing lercanidipine
|
AU2004319243B2
(en)
|
2003-05-28 |
2010-06-03 |
Aquestive Therapeutics, Inc. |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US20060165790A1
(en)
|
2003-06-27 |
2006-07-27 |
Malcolm Walden |
Multiparticulates
|
TWI357815B
(en)
|
2003-06-27 |
2012-02-11 |
Euro Celtique Sa |
Multiparticulates
|
EP1646367A4
(en)
|
2003-07-21 |
2011-06-15 |
Nesher Solutions Ltd |
ORAL DOSAGE FORMS WITH CONTROLLED RELEASE ON GELLAN RUBBER BASE A NEW PLATFORM TECHNOLOGY FOR MAGNETIC RETENTION
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE102004020220A1
(de)
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
US20070183980A1
(en)
*
|
2003-08-06 |
2007-08-09 |
Elisabeth Arkenau-Maric |
Dosage form that is safeguarded from abuse
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US20050053655A1
(en)
|
2003-09-05 |
2005-03-10 |
Pharmaceutical Industry Technology And Development Center |
Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same
|
EA200600598A1
(ru)
|
2003-09-19 |
2006-08-25 |
Пенвест Фармасьютикалз Ко. |
Лекарственные формы замедленного высвобождения
|
CA2540056C
(en)
|
2003-09-26 |
2015-03-24 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
EP1677768A4
(en)
|
2003-10-03 |
2011-06-29 |
Elite Lab Inc |
PROLONGED RELEASE OPIOID FORMULATIONS AND METHOD OF USING THE FORMULATIONS
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
US8883204B2
(en)
|
2003-12-09 |
2014-11-11 |
Purdue Pharma L.P. |
Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
|
DK1547670T3
(da)
|
2003-12-17 |
2008-01-07 |
Ksb Ag |
Trykvekslersystem
|
EP1703894A1
(en)
|
2003-12-23 |
2006-09-27 |
ALZA Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
WO2005065654A2
(en)
|
2003-12-31 |
2005-07-21 |
Alpharma, Inc. |
Rosiglitazone formulations
|
EP1740156B8
(de)
|
2004-04-22 |
2012-07-11 |
Grünenthal GmbH |
Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreinchungsform
|
US8383154B2
(en)
|
2004-05-11 |
2013-02-26 |
Egalet A/S |
Swellable dosage form comprising gellan gum
|
EP1765292B1
(en)
|
2004-06-12 |
2017-10-04 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent drug formulations
|
EP1765298B1
(de)
|
2004-07-01 |
2012-10-24 |
Gruenenthal Gmbh |
Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreichungsform unter verwendung eines planetwalzenextruders
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
DE102004032103A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
AR053304A1
(es)
|
2004-07-01 |
2007-05-02 |
Gruenenthal Gmbh |
Formas farmaceuticas orales protegidas frente al abuso con liberacion controlada de (1r,2r)-3-(3 dimetilamino-1-etil-2metil-propil)fenol y procedimiento para su produccion.
|
PL1765303T5
(pl)
|
2004-07-01 |
2023-05-22 |
Grünenthal GmbH |
Tabletka doustna zabezpieczona przed nadużywaniem
|
DE102004038440A1
(de)
|
2004-08-07 |
2006-03-16 |
Ksb Aktiengesellschaft |
Drehzahlregelbarer Druckaustauscher
|
US7214315B2
(en)
|
2004-08-20 |
2007-05-08 |
Scott Shumway |
Pressure exchange apparatus with integral pump
|
US20070281007A1
(en)
|
2004-08-27 |
2007-12-06 |
Jacob Jules S |
Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
|
WO2006030402A2
(en)
|
2004-09-17 |
2006-03-23 |
Ranbaxy Laboratories Limited |
Dual compartment osmotic delivery device
|
US20060110327A1
(en)
|
2004-11-24 |
2006-05-25 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
US20060177380A1
(en)
|
2004-11-24 |
2006-08-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
US20070231268A1
(en)
|
2004-11-24 |
2007-10-04 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
US20080152595A1
(en)
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
FR2889810A1
(fr)
|
2005-05-24 |
2007-02-23 |
Flamel Technologies Sa |
Forme medicamenteuse orale, microparticulaire, anti-mesurage
|
FR2881652B1
(fr)
|
2005-02-08 |
2007-05-25 |
Flamel Technologies Sa |
Forme pharmaceutique orale microparticulaire anti-mesuage
|
KR100822519B1
(ko)
|
2005-02-15 |
2008-04-16 |
주식회사종근당 |
위장 내에서 제어방출되는 단일 매트릭스 정제
|
US20060228413A1
(en)
|
2005-02-28 |
2006-10-12 |
Penwest Pharmaceuticals Co. |
Controlled release venlafaxine formulations
|
JP2008534564A
(ja)
|
2005-03-28 |
2008-08-28 |
オレクソ・アクチエボラゲット |
痛みの治療に有用な新しい製薬組成物
|
GB0506982D0
(en)
|
2005-04-06 |
2005-05-11 |
Mw Encap Ltd |
Abuse resistant capsules
|
US20090274759A1
(en)
|
2005-06-03 |
2009-11-05 |
Egalet A/S |
Solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids
|
PE20070325A1
(es)
|
2005-06-29 |
2007-05-12 |
Alza Corp |
Formas de dosificacion oral que comprenden compuestos derivados de carbamato
|
US8858993B2
(en)
|
2005-07-25 |
2014-10-14 |
Metrics, Inc. |
Coated tablet with zero-order or near zero-order release kinetics
|
US20080166407A1
(en)
|
2005-07-29 |
2008-07-10 |
Shalaby Shalaby W |
Solid oral formulations for combination therapy
|
WO2007030754A2
(en)
|
2005-09-09 |
2007-03-15 |
Monosolrx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US8652529B2
(en)
|
2005-11-10 |
2014-02-18 |
Flamel Technologies |
Anti-misuse microparticulate oral pharmaceutical form
|
US20100172989A1
(en)
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090022798A1
(en)
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20090317355A1
(en)
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
BRPI0706753A2
(pt)
|
2006-01-21 |
2011-04-05 |
Abbott Gmbh & Co Kg |
forma de dosagem e método para a distribuição de fármacos de abuso
|
US20070264346A1
(en)
|
2006-02-16 |
2007-11-15 |
Flamel Technologies |
Multimicroparticulate pharmaceutical forms for oral administration
|
FR2898056B1
(fr)
|
2006-03-01 |
2012-01-20 |
Ethypharm Sa |
Comprimes resistant a l'ecrasement destines a eviter le detournement illicite
|
WO2007106550A2
(en)
|
2006-03-15 |
2007-09-20 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
CA2645855C
(en)
|
2006-03-16 |
2015-02-03 |
Tris Pharma, Inc. |
Modified release formulations containing drug-ion exchange resin complexes
|
CA2647809C
(en)
|
2006-03-24 |
2016-08-16 |
Auxilium Pharmaceuticals, Inc. |
Stabilized compositions containing alkaline labile drugs
|
US8465759B2
(en)
|
2006-03-24 |
2013-06-18 |
Auxilium Us Holdings, Llc |
Process for the preparation of a hot-melt extruded laminate
|
AU2007249947B2
(en)
|
2006-05-09 |
2013-03-21 |
SpecGx LLC |
Zero-order modified release solid dosage forms
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
US9023400B2
(en)
|
2006-05-24 |
2015-05-05 |
Flamel Technologies |
Prolonged-release multimicroparticulate oral pharmaceutical form
|
FR2901478B1
(fr)
|
2006-05-24 |
2015-06-05 |
Flamel Tech Sa |
Forme pharmaceutique orale multimicroparticulaire a liberation prolongee
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
CA2660649A1
(en)
|
2006-06-23 |
2007-12-27 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
|
JP2009541360A
(ja)
|
2006-06-23 |
2009-11-26 |
エラン・ファルマ・インターナショナル・リミテッド |
ナノ粒子状メロキシカムおよび制御放出ヒドロコドンを含む組成物
|
US8465776B2
(en)
|
2006-08-04 |
2013-06-18 |
Ethypharm |
Granule and orally disintegrating tablet comprising oxycodone
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
WO2008028047A2
(en)
|
2006-08-30 |
2008-03-06 |
Lab International Srl |
Bioadhesive film drug delivery system
|
WO2008027442A2
(en)
|
2006-08-30 |
2008-03-06 |
Theraquest Biosciences, Llc |
Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
US8211905B1
(en)
|
2007-05-22 |
2012-07-03 |
Pisgah Laboratories, Inc. |
Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
|
US8470361B2
(en)
|
2006-12-04 |
2013-06-25 |
Orexo Ab |
Non-abusable pharmaceutical composition comprising opioids
|
DE102006057364B4
(de)
|
2006-12-04 |
2011-08-25 |
Danfoss A/S |
Wasserhydraulische Maschine
|
CA2930487A1
(en)
|
2007-01-16 |
2008-07-24 |
Egalet Ltd. |
Use of i) a polyglycol and ii) an active drug substance for the preparation of a pharmaceutical composition for i)mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
US8329720B1
(en)
|
2007-05-22 |
2012-12-11 |
Pisgah Laboratories, Inc. |
Opioid salts and formulations exhibiting abuse deterrent and anti-dose dumping properties
|
WO2008148798A2
(en)
|
2007-06-04 |
2008-12-11 |
Egalet A/S |
Controlled release pharmaceutical compositions for prolonged effect
|
MX336861B
(es)
|
2007-09-13 |
2016-02-04 |
Cima Labs Inc |
Formulacion de farmaco resistente al abuso.
|
JP2011506318A
(ja)
|
2007-12-06 |
2011-03-03 |
デュレクト コーポレーション |
経口医薬製剤
|
JP2011506342A
(ja)
|
2007-12-06 |
2011-03-03 |
ペイン セラピューティクス インコーポレイテッド |
微粉化オピオイド組成物、製剤および剤形、ならびにそれらの製造方法
|
AU2008338207A1
(en)
|
2007-12-17 |
2009-06-25 |
Labopharm (Barbados) Limited |
Misuse preventative, controlled release formulation
|
CA2713128C
(en)
*
|
2008-01-25 |
2016-04-05 |
Gruenenthal Gmbh |
Pharmaceutical dosage form
|
KR101094231B1
(ko)
|
2008-02-18 |
2011-12-14 |
하나제약 주식회사 |
서방성 고형 제제 및 그의 제조방법
|
US8377453B2
(en)
|
2008-03-11 |
2013-02-19 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
US8372432B2
(en)
|
2008-03-11 |
2013-02-12 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
AU2009281537A1
(en)
|
2008-08-14 |
2011-06-30 |
Bioneer A/S |
Coated tablets with a remaining degradation surface over the time
|
DE102008044869A1
(de)
|
2008-08-29 |
2010-03-04 |
Danfoss A/S |
Umkehrosmosevorrichtung
|
NZ601200A
(en)
*
|
2008-09-18 |
2014-02-28 |
Purdue Pharma Lp |
Pharmaceutical dosage forms comprising poly(epsilon-caprolactone)
|
BRPI0917608B8
(pt)
|
2008-12-12 |
2021-05-25 |
Paladin Labs Inc |
formulação de droga oral para a redução de potencial efeito abusivo, processo para a fabricação de uma formulação de droga e seu uso
|
WO2010069050A1
(en)
|
2008-12-16 |
2010-06-24 |
Labopharm Inc. |
Misuse preventative, controlled release formulation
|
EP2700400A1
(en)
*
|
2009-01-26 |
2014-02-26 |
Egalet Ltd. |
Controlled release formulation with continuous efficacy
|
EP2393484A1
(en)
|
2009-02-06 |
2011-12-14 |
Egalet Ltd. |
Immediate release composition resistant to abuse by intake of alcohol
|
US8603526B2
(en)
|
2009-02-06 |
2013-12-10 |
Egalet Ltd. |
Pharmaceutical compositions resistant to abuse
|
GB0909680D0
(en)
|
2009-06-05 |
2009-07-22 |
Euro Celtique Sa |
Dosage form
|
AU2010265213B2
(en)
|
2009-06-24 |
2012-08-23 |
Egalet Ltd. |
Controlled release formulations
|
WO2010151741A1
(en)
|
2009-06-25 |
2010-12-29 |
Elite Laboratories, Inc. |
Abuse resistant oral dosage forms
|
ES2534908T3
(es)
|
2009-07-22 |
2015-04-30 |
Grünenthal GmbH |
Forma de dosificación de liberación controlada extruida por fusión en caliente
|
CN102639118B
(zh)
|
2009-07-22 |
2015-07-29 |
格吕伦塔尔有限公司 |
氧化稳定的抗干扰剂型
|
WO2011041414A1
(en)
|
2009-09-30 |
2011-04-07 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
WO2011079074A1
(en)
|
2009-12-24 |
2011-06-30 |
Acura Phamaceuticals, Inc. |
Pharmaceutical compositions for deterring misuse, abuse, and diversion
|
US20120321674A1
(en)
|
2011-02-17 |
2012-12-20 |
Michael Vachon |
Technology for Preventing Abuse of Solid Dosage Forms
|
US20110195989A1
(en)
|
2010-02-09 |
2011-08-11 |
Rudnic Edward M |
Controlled Release Formulations of Opioids
|
US20130022646A1
(en)
|
2010-02-09 |
2013-01-24 |
Rudnic Edward M |
Controlled Release Formulations of Opioids
|
JP6141583B2
(ja)
|
2010-02-24 |
2017-06-07 |
シマ ラブス インク. |
濫用耐性製剤
|
MX2013002293A
(es)
|
2010-09-02 |
2013-05-09 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
|
PL2611426T3
(pl)
|
2010-09-02 |
2014-09-30 |
Gruenenthal Gmbh |
Postać dawkowania zawierająca nieorganiczne sole, odporna na zgniatanie
|
JP5925778B2
(ja)
|
2010-09-02 |
2016-05-25 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
アニオン性ポリマーを含む不正使用抵抗性剤形
|
WO2012040651A2
(en)
|
2010-09-24 |
2012-03-29 |
QRxPharma Ltd. |
Controlled release formulations of opioids
|
US20120202838A1
(en)
|
2010-11-04 |
2012-08-09 |
Abbott Laboratories |
Drug formulations
|
GB201020895D0
(en)
|
2010-12-09 |
2011-01-26 |
Euro Celtique Sa |
Dosage form
|
EP2651399A2
(en)
|
2010-12-13 |
2013-10-23 |
Purdue Pharma LP |
Controlled release dosage forms
|
AP3815A
(en)
|
2010-12-22 |
2016-09-30 |
Purdue Pharma Lp |
Encased tamper resistant controlled release dosage forms
|
BR112013015939A2
(pt)
|
2010-12-23 |
2020-08-04 |
Purdue Pharma L.P. |
formas farmacêuticas orais sólidas resistentes à adulteração
|
MX2013009492A
(es)
|
2011-02-17 |
2014-07-30 |
Qrxpharma Ltd |
Tecnologia para prevenir el abuso de formas de dosificacion solidas.
|
DK2688556T3
(en)
|
2011-03-25 |
2015-08-03 |
Purdue Pharma Lp |
Pharmaceutical dosage forms with controlled release
|
RS56527B1
(sr)
|
2011-07-29 |
2018-02-28 |
Gruenenthal Gmbh |
Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
|
DK2736495T3
(da)
|
2011-07-29 |
2017-11-13 |
Gruenenthal Gmbh |
Misbrugsbestandig tablet som tilvejebringer øjeblikkelig frigivelse af lægemiddel
|
ES2583132T3
(es)
|
2011-09-16 |
2016-09-19 |
Purdue Pharma L.P. |
Formulaciones de liberación inmediata resistentes a alteración
|
US20140341984A1
(en)
|
2011-09-16 |
2014-11-20 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
EP2763664A2
(en)
|
2011-10-06 |
2014-08-13 |
Grünenthal GmbH |
Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist
|
CN103889456A
(zh)
|
2011-10-18 |
2014-06-25 |
普渡制药公司 |
丙烯酸类聚合物制剂
|
AR088875A1
(es)
|
2011-11-17 |
2014-07-16 |
Gruenenthal Gmbh |
Forma de dosis farmaceutica oral a prueba de manipulacion
|
WO2013077851A1
(en)
|
2011-11-22 |
2013-05-30 |
Watson Pharmaceuticals, Inc. |
Immediate release abuse deterrent tablet
|
EP2787978B1
(en)
|
2011-12-09 |
2016-09-21 |
Purdue Pharma LP |
Pharmaceutical dosage forms comprising poly(epsilon-caprolactone) and polyethylene oxide
|
BR112015000150A2
(pt)
|
2012-07-06 |
2017-06-27 |
Egalet Ltd |
composições farmacêuticas dissuasoras de abuso de liberação controlada
|
US10154966B2
(en)
|
2013-05-29 |
2018-12-18 |
Grünenthal GmbH |
Tamper-resistant dosage form containing one or more particles
|
AU2014273226B2
(en)
|
2013-05-29 |
2019-06-27 |
Grunenthal Gmbh |
Tamper resistant dosage form with bimodal release profile
|